NCT05065554 2025-12-05ACALA-R In Predominantly Demyelinating IgM Mediated NeuropathyDana-Farber Cancer InstitutePhase 2 Active not recruiting12 enrolled
NCT02180724 2025-11-26An Open-label, Phase 2 Study of ACP-196 in Subjects With Waldenström MacroglobulinemiaAcerta Pharma BVPhase 2 Active not recruiting107 enrolled 15 charts